Drug watchdog to change cost guidelines
The drugs watchdog Nice is to change the way it makes decisions on NHS treatments, bringing to an end decisions on care of terminally ill patients made solely on cost-efficiency grounds.
The National Institute for Health and Clinical Excellence announced yesterday it would be setting out new drug approval guidelines for “less common” illnesses on 2 January.